Twist Bioscience's Chief Legal: What Investors Need to Know
A senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
This article explains the balance between strong cryptography and practical attack vectors, illustrating why no system is perfectly immune to breaches.
28,220 articlesA senior executive at Twist BIOSCIENCE sold a sizable stake, sparking questions about insider activity. This article ...
Two data-focused tech players, Palantir and BigBear.ai, report quarterly numbers that investors watch closely. This g...
NVDY is pursuing income by selling Nvidia’s strongest move days, financing a roughly 60% distribution. The strategy b...
As Movado prepares for its Q1 2027 earnings, investors want clarity on demand, margins, and licensing deals. This gui...
A reality-TV star running for Los Angeles mayor isn’t just drama—it’s a real test of how city budgets, taxes, and pub...
Investors face a shifting news landscape as social media becomes the default source for market signals, even as many ...
SpaceX just shook the investor world again with a massive bond offering. This article breaks down what spacex's fundr...
Two popular global equity ETFs offer very different approaches. VT provides wide, low-cost exposure to the world, whi...
AbbVie stock recently surged to a fresh 52-week high, impressing bulls while raising questions about value. This guid...
Micron stock just dropped as traders weigh demand for memory parts against a backdrop of cyclical pricing. This artic...
Choosing between Vanguard S&P 500 Growth ETF and Invesco S&P SmallCap Revenue ETF often comes down to risk tolerance ...
As July 22 approaches, investors face a familiar crossroads: take a position before earnings or wait for the full pic...